|
Re: ...contest tally...
|
3
|
Resverlogix Corp.
|
Mar 02, 2019 01:22PM
|
|
Re: Apabetalone’s Positive Impact on COVID-19 in Human Lung Cells Published in Biomedicines
|
3
|
Resverlogix Corp.
|
Apr 21, 2021 05:09PM
|
|
Re: Share offering a win/win for shareholders?
|
3
|
Resverlogix Corp.
|
May 24, 2019 01:12PM
|
|
Re: Finance
|
3
|
Resverlogix Corp.
|
Aug 07, 2020 02:55PM
|
|
Re: How many of the RVX.WT's have been exercise?
|
3
|
Resverlogix Corp.
|
Dec 03, 2020 03:51PM
|
|
Re: Presentation is gone - Nose growing
|
3
|
Resverlogix Corp.
|
May 16, 2021 11:51PM
|
|
Re: Clarification on BETonMACE baseline data
|
3
|
Resverlogix Corp.
|
Sep 09, 2019 06:29PM
|
|
Welcome to the RVX Hub - Telepanel
|
3
|
Resverlogix Corp.
|
Nov 08, 2019 05:21PM
|
|
Re: Hump Day Fun
|
3
|
Resverlogix Corp.
|
Mar 29, 2023 02:50PM
|
|
Re: MACE Event rate,....
|
3
|
Resverlogix Corp.
|
Feb 28, 2019 01:29PM
|
|
Re: Heavier than normal trading on the OTC for RVXCF
|
3
|
Resverlogix Corp.
|
Mar 15, 2017 06:25PM
|
|
Re: And there's the news, 3 month loan extension....
|
3
|
Resverlogix Corp.
|
May 04, 2019 04:09PM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
3
|
Resverlogix Corp.
|
Jan 09, 2019 04:19PM
|
|
Re: Offering still available....
|
3
|
Resverlogix Corp.
|
May 28, 2019 05:26PM
|
|
Re: NR: Resverlogix Highlights Key Accomplishments and 2018 Targets...
|
3
|
Resverlogix Corp.
|
Feb 09, 2018 04:12PM
|
|
Re: ... just for whatever reason...
|
3
|
Zenith Epigenetics
|
Jan 20, 2019 12:38PM
|
|
Re: Debt and 28 August
|
3
|
Resverlogix Corp.
|
Jul 28, 2017 10:17AM
|
|
Re: New Share Price Contest
|
3
|
Resverlogix Corp.
|
Oct 11, 2019 03:40PM
|
|
Re: AACR 2018
|
3
|
Zenith Epigenetics
|
Mar 06, 2018 03:46AM
|
|
Re: Interesting.
|
3
|
Resverlogix Corp.
|
Nov 22, 2021 04:42PM
|
